Biolidics made the announcement on July 14 that the company had entered into the agreement on July 9.
SINGAPORE (July 15): Singapore-based medical technology firm Biolidics has prompted a query from the Singapore Exchange Regulation (SGX RegCo) following the delayed announcement of its licensing agreement with Accelerate Technologies.
In the query at 2.31pm on Wednesday, SGX RegCo has asked Biolidics for its reasons on the delay of the announcement, whether the company’s sponsor was aware of the disclosure of the matter, and when the announcement was approved.
